67
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Outcomes and hemodynamics of Enable bioprosthesis in 432 patients: an afterword

ORCID Icon, ORCID Icon, , , , , , , , , & show all
Pages 291-296 | Received 03 Mar 2020, Accepted 02 Jun 2020, Published online: 14 Jul 2020

References

  • Hufnagel CA, Harvey WP, Rabil PJ, et al. In the beginning. Surgical correction of aortic insufficiency. Ann Thorac Surg. 1989;47(3):475–476.
  • Beckmann A, Meyer R, Lewandowski J, et al. German Heart Surgery Report 2018: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2019;67(5):331–344.
  • Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3):142–147.
  • de Oliveira Sa MPB, Cavalcanti LRP, Perazzo AM, et al. Calcific aortic valve stenosis and atherosclerotic calcification. Curr Atheroscler Rep. 2020;22(2):2.
  • Schaefers H-J, Boehm M. Ursachen und Behandlungsstrategien der Aortenklappeninsuffizienz. Dtsch Arztebl Int. 2004;101:A-2475.
  • Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart survey on valvular heart disease. Eur Heart J. 2003;24(13):1231–1243.
  • Charlson E, Legedza ATR, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. 2006;15:312–321.
  • Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart. 2013;99(6):396–400.
  • Falk V, Baumgartner H, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2017;52(4):616–664.
  • Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (London, England). 2015;385(9986):2485–2491.
  • Christ T, Zhigalov K, Konertz W, et al. Clinical outcome and hemodynamic behavior of the Labcor Dokimos Plus aortic valve. J Cardiothorac Surg. 2016;11(1):160
  • Silaschi M, Conradi L, Treede H, et al. Trends in surgical aortic valve replacement in more than 3,000 consecutive cases in the era of transcatheter aortic valve implantations. Thorac Cardiovasc Surg. 2015;64(05):382–389.
  • Christ T, Holinski S, Zhigalov K, et al. Hemodynamics of pericardial aortic valves: contemporary stented versus stentless valves in a matched comparison. Ann Thorac Cardiovasc Surg. 2017;23(6):298–303.
  • Sa M, Perazzo AM, Zhigalov K, et al. Aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium (Ozaki procedure) – a promising surgical technique. Brazil J Cardiovasc Surg. 2019;34:610–614.
  • Easo J, Weymann A, Hölzl P, et al. hospital results of a single center database for stentless xenograft use in a full root technique in over 970. Sci Rep. 2019;9(1):4371.
  • Takagi H, Umemoto T. A meta-analysis of sutureless or rapid-deployment aortic valve replacement. Thorac Cardiovasc Surg. 2015;64(05):400–409.
  • Zhigalov K, Khokhlunov M, Szczechowicz M, et al. Right anterior minithoracotomy for endocarditis after transcatheter aortic valve replacement. Ann Thorac Surg. 2020;109(1):e17–e19.
  • Wendt D, Thielmann M, Pizanis N, et al. Sutureless aortic valves over the last 45 years. Minim Invasive Ther Allied Technol. 2009;18(3):122–130.
  • Cox JL, Ad N, Myers K, et al. Tubular heart valves: a new tissue prosthesis design-preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg. 2005;130(2):520–527.
  • Wendt D, Thielmann M, Buck T, et al. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis. Eur J Cardiothorac Surg. 2008;33(4):542–547.
  • Aymard T, Kadner A, Walpoth N, et al. Clinical experience with the second-generation 3F Enable sutureless aortic valve prosthesis. J Thorac Cardiovasc Surg. 2010;140(2):313–316.
  • Martens S, Ploss A, Sirat S, et al. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Ann Thorac Surg. 2009;87(6):1914–1917.
  • Sadowski J, Kapelak B, Pfitzner R, et al. Sutureless aortic valve bioprothesis ‘3F/ATS Enable’ – 4.5 years of a single-centre experience. Kardiol Pol. 2009;67(8A):956–963.
  • Shalabi A, Raanani E, Shinfeld A, et al. Sutureless aortic valve: early and mid-term results at a single center. Isr Med Assoc J. 2016;18:119–123.
  • Stuhle S, Wendt D, Hou G, et al. Fluid dynamic investigation of the ATS 3F Enable sutureless heart valve. Innovations (Phila). 2011;6(1):37–44.
  • Eichstaedt HC, Easo J, Harle T, et al. Early single-center experience in sutureless aortic valve implantation in 120 patients. J Thorac Cardiovasc Surg. 2014;147(1):370–375.
  • Fujita B, Ensminger S, Bauer T, et al. Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients. Eur J Cardiothorac Surg. 2018;53(3):552–559.
  • Beckmann A, Meyer R, Lewandowski J, et al. German Heart Surgery Report 2017: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2018;66(8):608–621.
  • Englberger L, Carrel TP, Doss M, et al. Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3F Enable long-term follow-up study. J Thorac Cardiovasc Surg. 2014;148(4):1681–1687.
  • Fuzellier JF, Campisi S, Gerbay A, et al. two hundred consecutive implantations of the sutureless 3f enable aortic valve: what we have learned. Ann Thorac Surg. 2016;101(5):1716–1723.
  • Mashhour A, Zhigalov K, Szczechowicz M, et al. Snugger method – the Oldenburg modification of perceval implantation technique. World J Cardiol. 2018;10(9):119–122.
  • Szczechowicz M, Mashhour A, Chaduneli O, et al. Implantation of perceval valve in mitral position: a new technique. J Thorac Cardiovasc Surg. 2019;157(1):225–228.
  • Vola M, Campisi S, Gerbay A, et al. Sutureless prostheses and less invasive aortic valve replacement: just an issue of clamping time? Ann Thorac Surg. 2015;99(5):1518–1523.
  • Konertz J, Zhigalov K, Weymann A, et al. Initial experience with aortic valve replacement via a minimally invasive approach: a comparison of stented, stentless and sutureless valves. Med Sci Monit. 2017;23:1645–1654.
  • Ensminger S, Fujita B, Bauer T, et al. Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol. 2018;71(13):1417–1428.
  • Wendt D, Shehada S-E, Konig L, et al. Modified implantation height of the Sapien3 transcatheter heart valve. Minim Invasive Ther Allied Technol. 2020;29(2):70–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.